Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) Social Stream



Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): $2.16

0.01 (+0.47%)

POWR Rating

Get Rating

Component Grades

Growth

Get Rating

Value

Get Rating

Momentum

C

Stability

D

Sentiment

Get Rating

Quality

D

Add CANF to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#177 of 328

in industry
See All 'A' Rated Buy Stocks

Featured Post From StockTwits About CANF

$CANF CAN-FITE GEARS UP TO INITIATE PIVOTAL PHASE III LIVER CANCER STUDY

CAN FITE BIOPHARMA LTD - FDA GRANTED NAMODENOSON ORPHAN DRUG AND FAST TRACK STATUS bands so tighttttttttttttt
SEVENXStheGOAT, published August 8, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!